Avoro Capital Advisors LLC Puma Biotechnology, Inc. Transaction History

Avoro Capital Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$20.07 - $46.7 $23.1 Million - $53.7 Million	-1,150,685 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$41.2 - $59.85 $4.79 Million - $6.96 Million	116,310 Added 11.24%	1,150,685 $52.8 Million
Q2 2018 Aug 14, 2018	BUY	$48.3 - $68.25 $10.1 Million - $14.3 Million	209,007 Added 25.32%	1,034,375 $61.2 Million
Q1 2018 May 15, 2018	BUY	$59.7 - $99.25 $49.3 Million - $81.9 Million	825,368 New	825,368 $56.2 Million

102

29.1M

60.6K

16.3K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $132M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Avoro Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Avoro Capital Advisors LLC with notifications on news.